Biodesix
BDSX
46 hedge funds and large institutions have $82M invested in Biodesix in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 14 closing their positions.
253% more capital invested
Capital invested by funds: $23.2M → $82M (+$58.8M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
7% more funds holding
Funds holding: 43 → 46 (+3)
1.5% more ownership
Funds ownership: 0.84% → 2.34% (+1.5%)
95% less call options, than puts
Call options by funds: $1K | Put options by funds: $22K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$9.93M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$8.73M |
| 3 |
SCM
Sio Capital Management
New York
|
+$6.21M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.98M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$272K |
| 2 |
Millennium Management
New York
|
-$144K |
| 3 |
Jane Street
New York
|
-$133K |
| 4 |
Citigroup
New York
|
-$102K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$94.9K |
BDSX Hedge Fund Activity: Q2 2024 in Review
46 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2024, worth a combined $82M — up 253% from $23.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BDSX positions and 14 closed out — a net gain of 4 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was Telemark Asset Management, adding an estimated $9.93M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $272K sold.
- 46 institutional investors held Biodesix (BDSX) as of Q2 2024, up from 43 in Q1 2024.
- Funds reported $82M of Biodesix stock for Q2 2024, up 253% quarter-over-quarter.
- 18 funds opened new Biodesix positions in Q2 2024 and 14 closed out, a net change of +4 holders.
- The largest Biodesix buyer in Q2 2024 was Telemark Asset Management, an estimated $9.93M added.
- The largest Biodesix seller in Q2 2024 was Susquehanna International Group, an estimated $272K sold.
Based on aggregated 13F filings for Q2 2024.